Apotex acquires specialty drugmaker Searchlight in expansion move

2024-04-03

并购

Apotex acquires specialty drugmaker Searchlight in expansion move

Preview

来源: FiercePharma

Canadian generics maker Apotex is set to acquire Searchlight Pharma for an undisclosed price as part of a move to expand its offerings and operations.

Apotex, a Toronto-based generics maker, inked a deal to acquire fellow Canadian pharma company Searchlight Pharma.

The acquisition, which is expected to be completed by mid-year, is expected to boost Apotex’s expansion in the specialty branded pharma market with the addition of more than 60 products from Searchlight, the company said in an April 2 press release.

The companies didn't reveal the price of the buyout.

Searchlight's home office will remain in Montreal, and Apotex plans to expand its operations in the province of Quebec.

“This acquisition is a strategic complement to Apotex's leading market position in generic and biosimilar pharmaceuticals, in alignment with our ongoing focus to expand into the high-value, innovative branded pharmaceuticals sector,” Allan Oberman, Apotex president and CEO, said in the release.

Apotex was most recently in the news when it and two of its generics peers agreed in January in a Pennsylvania federal court to settle a price-fixing case that dated back to 2017.

The case, which also involved Heritage Pharmaceuticals and Breckenridge Pharmaceutical, involved claims of price fixing related to drugs they sold to direct purchasers.

更多内容，请访问原始网站

文中所述内容并不反映新药情报库及其所属公司任何意见及观点，如有版权侵扰或错误之处，请及时联系我们，我们会在24小时内配合处理。

机构